Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.
Zhao X, Mirza S, Alshareeda A, Zhang Y, Gurumurthy CB, Bele A, Kim JH, Mohibi S, Goswami M, Lele SM, West W, Qiu F, Ellis IO, Rakha EA, Green AR, Band H, Band V.
Zhao X, et al.
Breast Cancer Res Treat. 2012 Jul;134(1):171-80. doi: 10.1007/s10549-011-1946-8. Epub 2012 Jan 22.
Breast Cancer Res Treat. 2012.
PMID: 22270930
Free PMC article.